Milestone Pharmaceuticals’ CARDAMYST: A Promising Buy with FDA Decision and Phase 3 Trial on Horizon
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
Strategic Positioning and Financial Outlook: Ritu Baral’s Buy Rating on Milestone Pharmaceuticals Amidst Etripamil’s Promising Market Launch
TD Cowen analyst Ritu Baral maintained a Buy rating on Milestone Pharmaceuticals (MIST – Research Report) yesterday and set a price ...
My Apple watch helped doctors detect my heart condition after years of misdiagnosis
TikTok user Evie Clayton spent 10 years being told that she had anxiety, but later discovered she was actually suffering from ...